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release. Overall, this work suggests that macrophages can boost lysosome activity to handle successive rounds of phagocytosis.
INTRODUCTION
During phagocytosis, phagocytic cells like macrophages can engulf dozens of particles such as bacteria, fungi, and apoptotic bodies to clear an infection and maintain tissue homeostasis [1, 2] . Phagocytosis is a receptor and ligand-mediated process that can be classified as non-opsonic or opsonic. The former occurs when phagocytic receptors engage ligands endogenous to the particle, while the latter ensues through host-derived ligands that adhere to the particle [1, 2] . The best-studied example of opsonic phagocytosis employs immunoglobulin G (IgG) antibodies that bind to specific epitopes displayed on the particle [3] . Fcg receptors then recognize IgG-opsonized pathogens [4, 5] . Regardless of route, ligand-receptor engagement elicits a complex signaling pathway that restructures the plasma membrane of the phagocyte to ultimately internalize and sequester the particle within a phagosome [1, 2] . Phagosomes then fuse with lysosomes to mature into phagolysosomes, acquiring an acidic and hydrolytic lumen by acquiring the V-ATPase H + pump and a multitude of hydrolytic enzymes-the engulfed particle is consequently destroyed [1, 6, 7] . Unfortunately, many human pathogens, including Mycobacteria and Salmonella, evolved mechanisms to alter phagosome maturation and ensure their survival within host cells [8] [9] [10] [11] .
Phagosome maturation depends on a variety of lysosomal regulators including the Rab7 and Arl8b GTPases, and the PIKfyve lipid kinase, which synthesizes phosphatidylinositol-3,5-bisphosphate [PtdIns(3,5)P 2 ] [12] [13] [14] . In part, PIKfyve is required for phagosome-lysosome fusion by stimulating MCOLN1/TRPML1 (herein MCOLN1), a lysosomal Ca 2+ channel that binds to PtdIns(3,5)P 2 to release lysosomal Ca 2+ and trigger membrane fusion [15, 16] .
Indeed, silencing of MCOLN1 trapped lysosomes and phagosomes in a futile, docked step [16] . Interestingly, phagocytosis caused a prolonged increase in cytosolic Ca 2+ that depended on MCOLN [16] . Given that Ca 2+ is a versatile second messenger that controls many cellular functions [17] , this suggests that lysosomal Ca 2+ released during phagosome maturation may have additional functions other than triggering phagosome-lysosome fusion.
MCOLN1 is also required to activate the transcription factor EB (TFEB) in autophagy, a process during which cytosolic components are sequestered into autophagosomes that then fuse with lysosomes to degrade and release energy sources during starvation [18] . TFEB governs expression of the ''Coordinated Lysosomal Expression And Regulatory'' (CLEAR) gene network, which includes numerous lysosomal hydrolases, membrane proteins, and acidification proteins [19] [20] [21] [22] . Thus, activation of TFEB enhances lysosome gene expression to serve the increased catabolic demand during autophagy [19] [20] [21] [22] . Additionally, TFEB and the bHLH-30 ortholog in C. elegans were shown to enhance expression of host defense genes including cytokines and anti-microbial peptides in response to bacteria, suggesting that the CLEAR network is not limited to lysosomal genes [23] . However, this study did not investigate changes to lysosomal activity in response to infection.
Given that phagosomes fuse with lysosomes, and that a single macrophage can internalize dozens of bacteria, we hypothesized that phagocytosis activates TFEB. Indeed, here we show that phagocytosis stimulates lysosome-based degradation and bacterial killing by activating TFEB. This represents a feedback mechanism between phagosomes and lysosomes that likely helps to resolve infections.
RESULTS

Fcg-Receptor-Mediated Signaling Enhances Proteolytic and Bactericidal Activities in Macrophages
We first examined whether stimulation of Fcg receptors enhanced lysosome-based degradation in macrophages by treating bonemarrow-derived and RAW macrophages with aggregated IgG (AIgG) immune complexes and measuring the fluorescence intensity of DQ-BSA. DQ-BSA is internalized by pinocytosis and accumulates in lysosomes, where its degradation is tracked by increased fluorescence [24] . To account for possible effects on pinocytic uptake that might confound our interpretation, we normalized DQ-BSA fluorescence against the fluorescence signal of co-endocytosed fluorescent dextran for each experiment. Strikingly, we observed a significant increase in the normalized DQ-BSA signal 4-hr post-treatment with AIgG relative to control cells ( Figures 1A and 1B) . We then predicted that this enhanced lysosome-based degradation would strengthen bacterial killing. To test this, we allowed macrophages to endocytose AIgG immune complexes or engulf IgG-opsonized beads, followed by phagocytosis of live E. coli 4-hr post-Fcg receptor stimulation. While there was no difference in the uptake of E. coli, we found that, relative to non-stimulated macrophages, Fcg-receptor-activated macrophages killed E. coli more effectively ( Figures 1C and  1D) . Similarly, macrophages that internalized IgG-opsonized E. coli were better at killing subsequently internalized E. coli expressing an antibiotic-resistance gene ( Figure 1D ). Overall, our data show that engagement of Fcg receptors, either by endocytosis or phagocytosis, increases lysosome-based degradation and bacterial killing.
Fcg Receptor Engagement Causes TFEB Translocation into the Nucleus
To explain the enhanced lysosome-based degradation and bacterial killing, we postulated that Fcg receptor signaling stimulated TFEB [20, 21] . Indeed, AIgG or IgG beads increased the percentage of cells with nuclear TFEB-GFP after 40 min ( Figures  2A and 2B ), followed by a decrease at 12 hr ( Figure 2B ). These . Macrophages remained resting or were stimulated with AIgG for the indicated times, followed by co-endocytosis and chase of DQ-BSA and fluorescent-dextran into lysosomes. Using microscopy or flow cytometry, the fluorescence intensities for DQ-BSA and dextran per cell were quantified and the former normalized against the latter for each cell to account for possible differences in pinocytosis caused by AIgG. (C and D) Quantitation of bactericidal activity in primary macrophages (C) and RAW macrophages (D). Macrophages were either untreated cells (control), stimulated with AIgG, or allowed to ingest IgG-opsonized beads (OB) or IgG-opsonized E. coli, followed by phagocytosis of live E. coli as described in Experimental Procedures. Macrophages were then immediately lysed or allowed to mature their phagosomes before lysis to, respectively, estimate the rate of phagocytosis (Internalized) and killing (Survived). Data are shown as a normalized mean ± SEM for three to six independent experiments, where * indicates statistical significance (p < 0.05) against control conditions using Student's t test (A and B) or ANOVA followed by Tukey's post hoc test (C and D).
kinetics were similar for cells treated with torin1, an inhibitor of mTOR [22, 25] . To measure the robustness of TFEB activation, we quantified the nuclear-to-cytosolic ratio of TFEB-GFP. AIgG and torin1 both increased this ratio significantly, though torin1 was more robust at 4 and 12 hr ( Figure S1A ).
To ensure that our observations were not an artifact of TFEB-GFP overexpression, we assessed the localization of endogenous TFEB. We obtained a weak diffused signal when cells were stained with anti-TFEB antibodies. To ascertain that this corresponded to endogenous TFEB and not non-specific background fluorescence, we silenced TFEB. Both western blotting and immunofluorescence analyses showed strong TFEB silencing relative to non-targeting oligonucleotides ( Figure S2 ). This confirms that the immunofluorescence signal, albeit weak, was partially derived from endogenous TFEB ( Figure S2 ). We then showed that AIgG increased the nuclear-to-cytosolic signal of RAW cells stained for TFEB in non-targeting small interfering RNA (siRNA)-treated cells, while little response was observed in cells silenced for TFEB (Figures 2C and S2B) . Similarly, we showed that primary macrophages exhibited an increase in nuclear-to-cytosolic endogenous TFEB after AIgG stimulation ( Figure 2D ). Overall, these data suggest that FcgR engagement stimulates endogenous TFEB in macrophages. Interestingly, TFEB activation does not appear to be a general response to macrophage activation since treatment with interferon-g 
Fcg-Receptor-Mediated Signaling Increases Expression of Specific TFEB Target Genes
To determine whether TFEB nuclear accumulation after Fcg receptor activation enhances lysosome gene expression, we quantified the relative expression of a select group of TFEB target genes [20] . We found that phagocytosis of IgG-opsonized beads caused a significant increase in expression of Ctsd and Atp6v1h mRNA, which, respectively, encode for the lysosomal protease cathepsin D (CTSD) and the H subunit (ATP6V1H) of the vacuolar-type proton ATPase (V-ATPase) ( Figure 3A ). However, we did not observe a significant change in expression of Lamp1 and Mcoln1, which encode for the lysosomal-associated membrane protein 1 (LAMP1) and MCOLN1, respectively ( Figure 3A ). Moreover, we also found that the expression of Map1lc3, encoding LC3, was boosted by phagocytosis, but not other autophagy genes such as Atg5 and Becn1 [19, 21] . This contrasts with mTOR inhibition, which significantly stimulated expression of most genes tested (Figure 3A) . The enhanced transcription of Atp6v1h and Ctsd was accompanied by a significant increase in ATP6V1H and CTSD protein levels, while LAMP1 remained constant, for cells stimulated with IgG beads ( Figure 3B ). Notably, Fcg-receptor stimulation failed to increase the protein levels of CTSD and ATP6V1H in TFEB-silenced cells ( Figure 3C ). Moreover, TFEB silencing did not alter the basal levels of CTSD, ATP6V1H or LAMP1 ( Figure 3C ), which suggests (1) that TFEB may not control basal lysosome biogenesis or (2) that residual TFEB may suffice to maintain basal lysosome function. Regardless, our results indicate that Fcg receptor signaling does not appear to globally control the CLEAR gene network but targets a subset of lysosomal enzymes. Consistent with this, we did not observe a difference in lysosome number between resting, torin1-treated, or AIgG-treated cells ( Figure S3D ).
TFEB Is Required for the Fcg-Receptor-Dependent Augmentation in Bacterial Killing
We next postulated that TFEB was necessary for the enhanced lysosome-based degradation and bacterial killing after Fcg receptor engagement. To test this, we silenced TFEB in RAW macrophages and re-deployed the DQ-BSA degradation and bactericidal assays before and after Fcg receptor stimulation. Cells electroporated with non-targeting siRNA oligonucleotides displayed superior DQ-BSA proteolysis in response to AIgG exposure relative to unstimulated cells ( Figures 4A and  S4) . Remarkably, non-stimulated and AIgG-stimulated cells had similar DQ-BSA degradation when silenced for TFEB expression using either pooled siRNA oligonucleotides or either one of two independent oligonucleotides against TFEB ( Figures 4A and S4) . Furthermore, cells silenced for TFEB expression were also impaired for the enhanced bacterial killing in response to AIgG exposure, while cells electroporated with non-targeting oligonucleotides preserved this phenomenon ( Figure 4B ). As before, none of the treatments employed affected E. coli engulfment ( Figure 4B ). Notably, basal proteolytic and bactericidal activity remained unchanged after TFEB silencing, possibly because residual TFEB is sufficient for this, or because TFEB does not control basal lysosome biogenesis. Overall, these data support the hypothesis that TFEB directly mediates the enhancement of lysosome proteolysis and bacterial killing in macrophages whose Fcg receptors were activated.
Fcg Receptor Signaling Is Insufficient for TFEB Nuclear Translocation
We next examined whether TFEB nuclear translocation occurs upon Fcg receptor activation but in the absence of uptake by employing frustrated phagocytosis [26] . RAW macrophages transfected with TFEB-GFP were parachuted onto BSA-coated or IgG-coated coverslips and allowed to attach. Since the coverslip surface is too large, phagosomes cannot form, leading to frustrated phagocytosis. Macrophages that attached to IgGopsonized coverslips acquired phosphorylated Syk, a proximal signaling event downstream of Fcg receptors ( Figure 5A [27, 28] ). In comparison, there was no detectable phospho-Syk in cells parachuted onto BSA-coated coverslips ( Figure 5A ). Notwithstanding the accumulation of phospho-Syk, TFEB remained cytosolic after frustrated phagocytosis ( Figures 5B, 5C , and S1B). These data suggest that activation of Fcg receptors is not sufficient to trigger nuclear translocation of TFEB. We propose that TFEB activation may require internalization of activated Fcg receptors and/or particle enclosure.
TFEB Nuclear Accumulation Is Dependent on Lysosomal Calcium Release
Our data suggest that some aspect of phagocytosis or phagosome maturation activates TFEB. It is unlikely that this happens by repressing mTOR since phagocytosis increases the levels of phospho-S6K, a substrate of mTOR [29] , ( Figure S5A ). Instead, given (1) was at least in part responsible for TFEB-GFP nuclear accumulation, we employed siRNA against MCOLN1. Indeed, while Fcgreceptor-mediated phagocytosis retained the ability to induce TFEB nuclear accumulation after non-targeting siRNA treatment, MCOLN1 silencing arrested TFEB-GFP nuclear accumulation in response to phagocytosis ( Figures 6C, 6D , and S1). TFEB-GFP translocation was rescued in cells expressing human MCOLN, which is resistant to the murine silencing oligonucleotides (Figures S5B and S5C) . Overall, our data suggest that TFEB nuclear translocation depends on lysosomal Ca 2+ released by MCOLN1, likely during phagolysosome biogenesis.
Non-opsonic Phagocytosis of E. coli Activates TFEB and Enhances Lysosomal Degradation We next pondered whether other phagocytic signals might activate TFEB to enhance lysosomal activity. To assay this, we exposed macrophages to non-opsonized E. coli. Since E. coli exhibit multiple endogenous ligands, then phagocytosis of E. coli likely proceeds through cooperative engagement of several receptors including lectins, scavenger receptors, and TLR4 [2, [30] [31] [32] . Indeed, while TFEB-GFP was predominantly cytosolic in resting macrophages, E. coli engulfment caused TFEB nuclear translocation ( Figures 7A and 7B ). Importantly, macrophages that internalized unopsonized E. coli displayed a significant increase in lysosome-based proteolysis using the DQ-BSA assay relative to resting macrophages ( Figure 7C ). Strikingly, cells electroporated with the non-targeting oligonucleotides, but not those silenced for TFEB, showed a robust enhancement in lysosome-based degradation after phagocytosis of E. coli ( Figure 7D ). Overall, this suggests that phagocytosis of non-opsonized bacteria can also stimulate TFEB to enhance lysosome-based degradation.
DISCUSSION
Immune cells evolved intricate molecular networks to sense and heighten their ability to resolve an infection. This is understood to occur through paracrine and autocrine signals governed by the release of cytokines that orchestrate inflammation and its resolution [33] . Cytokine production is tightly modulated at the transcriptional level by various transcription factors including the canonical necrosis factor kB (NF-kB) and NF-AT proteins [reviewed in [34, 35] . However, much less is known about how transcriptional switches help cells adapt their organellar function in response to infection and other immune cues. Here, we show that Fcg receptor engagement activates the transcription factor TFEB to boost lysosome-based degradation and bacterial killing. Thus, we have uncovered a novel phenomenon during which the uptake of IgG immune complexes trains macrophages to become better killers, in part by super-activating their lysosomes through a transcriptional circuit. Importantly, a similar process occurs in macrophages undertaking phagocytosis of non-opsonized E. coli, suggesting that this is not limited to Fcg receptors. We speculate that this ''training'' is important to help macrophages dispose of the dozens of pathogens that can be engulfed by a single macrophage [36, 37] . Our results further bolster recent reports that link TFEB to immune processes. First, TFEB expression toggles the ability of dendritic cells to mediate antigen cross-presentation. In particular, TFEB overexpression favors major histocompatibility complex class II (MHC-II)-dependent antigen presentation by enhancing lysosome hydrolytic activity and acidification, while its suppression prioritizes MHC-I-antigen presentation by reducing lysosome activity and preserving exogenous antigens [38]. Second, Visvikis et al. elegantly showed that the TFEB ortholog in C. elegans, bHLH-30, is activated by infection with S. aureus and is responsible for upregulating the majority of immune and cytoprotective genes in that model organism [23] . They also showed that S. aureus activated TFEB in RAW macrophages and was necessary for increased expression of immunerelated genes [23] . It is thus evident that opsonins like IgG and endogenous ligands on S. aureus and E. coli can stimulate TFEB in macrophages. It will now be important to identify the range of immune signals that modulate TFEB, including other Fc receptors and Toll-like receptors.
Interestingly, Fcg receptor engagement did not lead to a global upregulation of lysosome and autophagy-related genes known to be controlled by TFEB [20, 21] . Indeed, while mTOR inhibition increased five out of the seven genes tested, only Ctsd and Atp6v1h exhibited significant increases in expression and protein levels after Fcg receptor engagement relative to control cells. This suggests that IgG immune complexes do not induce full-scale lysosome biogenesis to increase lysosome number, but rather may bolster the ability of existing lysosomes or serve to replace enzymes that might be lost during particle breakdown. Additionally, MITF and TFE3 also translocate to the nucleus upon Fcg receptor activation (data not shown). Together, this suggests that TFEB and its related transcription factors may differentially modulate different sets of genes. This is consistent with the evidence that TFEB and related factors respond to diverse physiological cues including autophagy, lysosome stress, WNT signaling, S. aureus, E. coli, and IgG immune complexes [19, 21, 23, 39] . Given this diversity of inputs, one might expect different sets of signaling pathways to combine to allow TFEB to express subsets of genes in response to a specific input. For example, this could be achieved by differential phosphorylation of 12 potential sites on TFEB [40] . Future research, including transcriptomics, will be required in order to understand how TFEB can selectively target gene subsets under various conditions.
Finally, TFEB activation may require phagosome formation, Ca 2+ and MCOLN1. With respect to the former, we expect that signals that arrest engulfment will interfere with TFEB activation. With respect to the latter, we speculate that Ca 2+ -released by MCOLN1 during phagosome maturation activates the protein phosphatase calcineurin, causing dephosphorylation at inhibitory sites of TFEB and ultimately its nuclear translocation. This model is consistent with two keys observations. First, we previously showed that MCOLN1 is necessary for phagosome-lysosome fusion, causing an apparent decrease in lysosomal Ca 2+ stores and an increase in cytosolic Ca 2+ levels [16] . Second, TFEB nuclear translocation during autophagic stress also required MCOLN1 and the consequent calcineurin stimulation [18] . It will be interesting to see whether other forms of phagocytosis also induces TFEB activation through a similar mechanism and whether pathogens that interfere with phagosome-lysosome fusion such as Mycobacterium tuberculosis prevent TFEB stimulation [41] . Indeed, given that TFEB overexpression seems to help resolve some defects in lysosomal storage diseases [42, 43] , it will be critical to evaluate the therapeutic power of TFEB during infection. While our studies employ siRNA-based technology, future studies will benefit from CRISPR/Cas9-based gene manipulation and/or macrophagespecific gene deletion of TFEB.
EXPERIMENTAL PROCEDURES
Cell Culture, Transfection, and Electroporation RAW 264.7 mouse macrophages were cultured in DMEM supplemented with 5% (v/v) fetal bovine serum (FBS; GIBCO). Transfection of plasmids encoding GFP-fusion of TFEB [22] were carried out using PolyJet DNA transfection reagent (FroggaBio) or FuGene HD transfection reagent (Promega) following manufacturers' instructions for 12-well plates. siRNA-mediated gene silencing was carried out using the Neon Electroporation System (Life Technologies) following the manufacturer's instructions. To silence TFEB, we used the ONTARGETplus SMARTpool or individual oligonucleotides from the SMART pool against murine Tfeb (Oligo 1 is J-050607-17 and Oligo 2 is J-050607-20; GE Dharmacon), while the non-targeting control cells were electroporated with ON-TARGETplus Non-targeting Pool oligonucleotides (GE Dharmacon). Cells underwent siRNA electroporation twice, separated by 24 hr, with a 24-hr period following the second round of electroporation prior to use in assays. MCOLN1 silencing and rescue was carried out as previously described ( [16] ; see Supplemental Experimental Procedures). Primary mouse macrophages were differentiated from bone-marrowderived monocytes from femurs and tibias dissected from euthanized mice (see Supplemental Experimental Procedures for details). Mice were used according to ethical protocols for research animals approved by Ryerson University and St. Michael's Hospital Animal Care Committee.
Treatments
Aggregated IgG (AIgG) was prepared by heating human serum IgG (Sigma Aldrich) at 62 C for 20 min and then centrifuged at 16,000 3 g for 10 min.
IgG-opsonized beads (OBs) were generated by rotating 3.87-or 2.08-mm poly(styrene/divinylbenzene) beads (Bangs Laboratories) with IgG from human serum for 20 min at room temperature, prior to 33 wash with PBS. Torin1 was applied at 100 nM for the period of time specified for each individual experiment. 1,2-bis(o-aminophenoxy)ethane-N,N,N 0 ,N 0 -tetraacetic acid acetoxymethyl (BAPTA-AM) was applied at 10 mM for 40 min immediately after stimulation with AIgG or IgG-opsonized beads. E. coli phagocytosis was carried out by growing DH5a E. coli to log phase (OD 600 0.6) and then applying to macrophages at 1,000 bacteria/macrophage for TFEB-GFP nuclear localization or at 50 bacteria/macrophage for the DQ-BSA assay. E. coli phagocytosis was synchronized through centrifugation of the plates at 400 3 g for 5 min at room temperature. See Supplemental Information for frustrated phagocytosis treatments, western blotting, and qRT-PCR.
Fluorescence Staining and Microscopy TFEB-GFP-transfected cells were left untreated or treated with torin1, AIgG, IgG-opsonized beads, or E. coli. AIgG and IgG-opsonized beads were applied to cells for 20 min, followed by a chase (30 min to 24 hr), while torin1 was applied continuously. After the indicated time, cells were fixed with 4% (v/v) paraformaldehyde and stained with 0.4 mg/ml DAPI. For phagocytosis of live E. coli, TFEB-GFP expressing macrophages were allowed to internalize for 5 min after spinning bacteria onto the macrophage surface. Macrophages were then treated for 30 min with media containing antibiotics to kill external bacteria. Antibiotic containing media was then removed, and cells were incubated for the indicated time prior to fixation. E. coli were stained using an anti-E. coli primary antibody and an Alexa-647-conjugated secondary antibody. For endogenous TFEB localization, cells remained resting or were treated as described above with AIgG for 20 min followed by a 1.5-hr chase or torin1 for 2 hr continuously. Cells were then fixed and permeabilized with 0.1% (v/v) Triton X-100 in PBS, and TFEB was labeled with a rabbit anti-TFEB primary antibody (1:1,000 dilution in 0.5% BSA in PBS) followed by an Alexa-546 conjugated donkey anti-rabbit secondary antibody (1:1,000 dilution in 0.5% BSA in PBS). Cells were then DAPI stained prior to mounting. See Supplemental Information for imaging analysis details.
DQ-BSA Proteolysis
Cells were treated with AIgG or live E. coli continuously for indicated times prior to lysosome loading. Lysosome labeling was done by co-endocytosis of 2 mM fixable Alexa-647-conjugated 10 kDa dextran (Life Technologies) See Figure S1 for additional information.
and 10 mg/ml DQ Green BSA (Life Technologies) for 15 min, followed by a 1-hr chase in label-free media. Cells were then scraped from wells in PBS and analyzed for whole-cell fluorescence using the BD FACSCalibur flow cytometer (BD Biosciences), where 10,000 events were counted per sample per condition using the fluorescein isothiocyanate (FITC) (FL1) and Cy5 (FL4) channels. Background signal was determined with non-labeled cells. The DQ-BSA signal (FITC/FL1 channel) was then normalized against the Alexa-647-dextran signal (Cy5/FL4 channel). Alternatively, DQ-BSA fluorescence was analyzed by microscopy using the Olympus system by stimulating cells with a 30-min pulse of AIgG followed by a 3.5-hr chase. Cells were then loaded with DQ-BSA as above but using fixable Alexa-546-conjugated 10 kDa dextran (Life Technologies) in place of Alexa-647 dextran. Following a chase period of 1 hr, cells were fixed and imaged. Fluorescent intensities were analyzed using ImageJ by normalizing the DQ-BSA fluorescence signal against the Alexa-546 signal after background correction.
Bactericidal Colony Assay
Bacteria killing assays were carried out as previously described [16] , with some alterations. Prior to phagocytosis of unopsonized E. coli, RAW or primary macrophages remained untreated or were activated with AIgG or IgG-opsonized beads for 20 min, followed by a 3.5-hr chase. For RAW cells treated with opsonized E. coli, DH5a E. coli was opsonized with an anti-E. coli rabbit polyclonal antibody at a dilution of 1:100 in PBS. Bacteria were then applied to macrophages at 50 bacteria/macrophage and synchronized through centrifugation. Non-adherent bacteria were removed through rinsing. Following 4 hr, macrophages were then allowed to phagocytose DH5a E. coli carrying an ampicillin-resistant plasmid. Each treatment was carried out in duplicate, with one replicate being lysed and plated immediately after gentamicin treatment, which was used to determine E. coli uptake. The remaining replicates were incubated for 5 hr, to allow for bacterial digestion, prior to lysis and plating. Colonies were counted on each set of plates after an overnight incubation. Lysates from cells treated with opsonized E. coli were plated on LBampicilin plates to select for bacteria carrying the ampicillin-resistance plasmid.
Statistical Analysis
All data were subject to statistical analysis using Student's t test or one-way ANOVA coupled to Tukey's post hoc test. Number of independent experiments performed is indicated in figure legends. For experiments using single-cell analysis, at least 100 cells were scored per condition per experiment. 
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